| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZNF609_0008800 | Intron-Exon-Intron | chr15:64961232-64973586 | chr15:64669033-64681387 | 53 nt | 0.3962 |
| hsa_ZNF609_0009200 | Exon-Exon | chr15:64962545-64968455 | chr15:64670346-64676256 | 88 nt | 0.4886 |
| hsa_ZNF609_0009100 | Exon-Exon | chr15:64962545-64974099 | chr15:64670346-64681900 | 250 nt | 0.4320 |
| hsa_ZNF609_0009300 | Intron-Exon-Intron | chr15:64962985-64968724 | chr15:64670786-64676525 | 250 nt | 0.3800 |
| hsa_ZNF609_0009500 | Exon-Exon | chr15:64966115-64968455 | chr15:64673916-64676256 | 2341 nt | 0.5297 |
| hsa_ZNF609_0009700 | Exon-Exon | chr15:64966115-64970681 | chr15:64673916-64678482 | 367 nt | 0.5668 |
| hsa_ZNF609_0009600 | Exon-Exon | chr15:64966115-64973586 | chr15:64673916-64681387 | 250 nt | 0.4400 |
| hsa_chr15_0219100 | Intergenic-Intergenic | chr15:64966140-64966505 | chr15:64673941-64674306 | 366 nt | 0.5519 |
| hsa_ZNF609_0009800 | Exon-Exon | chr15:64966267-64973577 | chr15:64674068-64681378 | 250 nt | 0.4560 |
| hsa_chr15_0219200 | Intergenic-Intergenic | chr15:64966596-64966986 | chr15:64674397-64674787 | 391 nt | 0.4783 |
A study in mice demonstrated that the circZNF609 exhibits higher expression in myotubes compared to myoblasts, and its downregulation reduces myoblast proliferation while inhibiting differentiation by sponging miR-194-5p and upregulating BCLAF1 [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review consolidating research across multiple species, including human, mouse, rat, and C. elegans, indicates that the circZNF609 is downregulated in Hirschsprung disease and functions as a miRNA sponge for miR-150-5p to regulate AKT3, where its silencing inhibits cell migration and proliferation [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. In mammalian neural tissue, it is also noted to play a role in myoblast differentiation by producing a protein [Suresh L. Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].